Finland· FI-REL-REL64462
Evlarco
A combinations of various lipid modifying agents product containing obicetrapib hemicalcium + ezetimibe, registered in Finland by A. Menarini International Licensing S.A.. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Obicetrapib hemicalcium + ezetimibe is registered in 2 of 19 countries.
Countries holding a registration under ATC C10BA (combinations of various lipid modifying agents), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 2 of them publish a price we can compare per daily dose
Obicetrapib hemicalcium + ezetimibe · ATC C10BA
2 / 19 countries
- Finlandprice
- Polandprice
The record
At a glance
Fimea (Finland)- Active substance
- Obicetrapib hemicalcium + Ezetimibe
- Manufacturer
- A. Menarini International Licensing S.A.
- Country
- Finland (FI)
- ATC code
- C10BA
- ATC class
- Combinations of various lipid modifying agents
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C10BA
Combinations of various lipid modifying agents, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e6fc7ebc-b298-4632-accf-025a175d0988 GET /v1/drugs/e6fc7ebc-b298-4632-accf-025a175d0988?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": null,
"strength": "10 mg/10 mg",
"atc_label": "Lipidejä muuntavien lääkeaineiden yhdistelmävalmisteet",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/26/2056/001-003",
"fimea_rel_id": "REL64462",
"authorised_at": "2026-09-18"
}See everything about obicetrapib hemicalcium + ezetimibe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.